Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Identifieur interne : 000938 ( PubMed/Checkpoint ); précédent : 000937; suivant : 000939Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Auteurs : M. Aidoo [Ghana] ; O. Nishiwaki ; H. Akari ; J A Brandful ; W. Ampofo ; M. Hayami ; N K AyisiSource :
- West African journal of medicine [ 0189-160X ]
Descripteurs français
- KwdFr :
- Anticorps anti-HTLVI (sang), Anticorps anti-VIH (sang), Ghana (épidémiologie), Humains, Surveillance de la population, Syndrome d'immunodéficience acquise (diagnostic), Syndrome d'immunodéficience acquise (immunologie), Syndrome d'immunodéficience acquise (épidémiologie), Syndrome pré-SIDA (diagnostic), Syndrome pré-SIDA (immunologie), Syndrome pré-SIDA (épidémiologie), Séroprévalence du VIH, Technique de Western, Études séroépidémiologiques.
- MESH :
- diagnostic : Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- immunologie : Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- sang : Anticorps anti-HTLVI, Anticorps anti-VIH.
- épidémiologie : Ghana, Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- Humains, Surveillance de la population, Séroprévalence du VIH, Technique de Western, Études séroépidémiologiques.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- AIDS-Related Complex (diagnosis), AIDS-Related Complex (epidemiology), AIDS-Related Complex (immunology), Acquired Immunodeficiency Syndrome (diagnosis), Acquired Immunodeficiency Syndrome (epidemiology), Acquired Immunodeficiency Syndrome (immunology), Blotting, Western, Ghana (epidemiology), HIV Antibodies (blood), HIV Seroprevalence, HTLV-I Antibodies (blood), Humans, Population Surveillance, Seroepidemiologic Studies.
- MESH :
- chemical , blood : HIV Antibodies, HTLV-I Antibodies.
- geographic , epidemiology : Ghana.
- diagnosis : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- epidemiology : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- immunology : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- Blotting, Western, HIV Seroprevalence, Humans, Population Surveillance, Seroepidemiologic Studies.
Abstract
Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).
PubMed: 7841103
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:7841103Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</title><author><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name><affiliation wicri:level="4"><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation><orgName type="university">Université du Ghana</orgName><country>Ghana</country><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name></author><author><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name></author><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name></author><author><name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name></author><author><name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name></author><author><name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1994 Jul-Sep</MedlineDate></PubDate></date><idno type="RBID">pubmed:7841103</idno><idno type="pmid">7841103</idno><idno type="wicri:Area/PubMed/Corpus">000414</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000414</idno><idno type="wicri:Area/PubMed/Curation">000414</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000414</idno><idno type="wicri:Area/PubMed/Checkpoint">000414</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000414</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</title><author><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name><affiliation wicri:level="4"><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation><orgName type="university">Université du Ghana</orgName><country>Ghana</country><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name></author><author><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name></author><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name></author><author><name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name></author><author><name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name></author><author><name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name></author></analytic><series><title level="j">West African journal of medicine</title><idno type="ISSN">0189-160X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Complex (diagnosis)</term><term>AIDS-Related Complex (epidemiology)</term><term>AIDS-Related Complex (immunology)</term><term>Acquired Immunodeficiency Syndrome (diagnosis)</term><term>Acquired Immunodeficiency Syndrome (epidemiology)</term><term>Acquired Immunodeficiency Syndrome (immunology)</term><term>Blotting, Western</term><term>Ghana (epidemiology)</term><term>HIV Antibodies (blood)</term><term>HIV Seroprevalence</term><term>HTLV-I Antibodies (blood)</term><term>Humans</term><term>Population Surveillance</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps anti-HTLVI (sang)</term><term>Anticorps anti-VIH (sang)</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Surveillance de la population</term><term>Syndrome d'immunodéficience acquise (diagnostic)</term><term>Syndrome d'immunodéficience acquise (immunologie)</term><term>Syndrome d'immunodéficience acquise (épidémiologie)</term><term>Syndrome pré-SIDA (diagnostic)</term><term>Syndrome pré-SIDA (immunologie)</term><term>Syndrome pré-SIDA (épidémiologie)</term><term>Séroprévalence du VIH</term><term>Technique de Western</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term><term>HTLV-I Antibodies</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>AIDS-Related Complex</term><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term><term>Syndrome pré-SIDA</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Complex</term><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term><term>Syndrome pré-SIDA</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>AIDS-Related Complex</term><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-HTLVI</term><term>Anticorps anti-VIH</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Syndrome d'immunodéficience acquise</term><term>Syndrome pré-SIDA</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blotting, Western</term><term>HIV Seroprevalence</term><term>Humans</term><term>Population Surveillance</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Surveillance de la population</term><term>Séroprévalence du VIH</term><term>Technique de Western</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7841103</PMID><DateCreated><Year>1995</Year><Month>03</Month><Day>08</Day></DateCreated><DateCompleted><Year>1995</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0189-160X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><MedlineDate>1994 Jul-Sep</MedlineDate></PubDate></JournalIssue><Title>West African journal of medicine</Title><ISOAbbreviation>West Afr J Med</ISOAbbreviation></Journal><ArticleTitle>Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</ArticleTitle><Pagination><MedlinePgn>150-1</MedlinePgn></Pagination><Abstract><AbstractText>Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aidoo</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishiwaki</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Akari</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Brandful</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Ampofo</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Hayami</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ayisi</LastName><ForeName>N K</ForeName><Initials>NK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Nigeria</Country><MedlineTA>West Afr J Med</MedlineTA><NlmUniqueID>8301891</NlmUniqueID><ISSNLinking>0189-160X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015481">HTLV-I Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000386" MajorTopicYN="N">AIDS-Related Complex</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015528" MajorTopicYN="N">HIV Seroprevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015481" MajorTopicYN="N">HTLV-I Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7841103</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country><region><li>Région du Grand Accra</li></region><settlement><li>Accra</li><li>Legon (Ghana)</li></settlement><orgName><li>Université du Ghana</li></orgName></list><tree><noCountry><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name><name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name><name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name><name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name><name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name></noCountry><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000938 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000938 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:7841103
|texte= Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:7841103" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |